Canterbury DHB

Context

Management of Tumour Lysis Syndrome

The features of tumour lysis can be present at presentation or may develop within hours of starting treatment:

In This Section

Aggressive Hydration

Rasburicase (recombinant form of urate oxidase)

Rasburicase Dosage

Hyperkalaemia

Hyperphosphataemia

Hypocalcaemia

Renal Failure

About this Canterbury DHB document (5737):

Document Owner:

Sean Macpherson (see Who's Who)

Last Reviewed:

January 2019

Next Review:

January 2022

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 5737